4.7 Article

The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)

Journal

JOURNAL OF TRANSLATIONAL MEDICINE
Volume 15, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12967-017-1212-x

Keywords

GIST; SDH; Quadruple wild-type; ETV6-NTRK3; MEN1; MAX; FGFR1

Ask authors/readers for more resources

Recent advances in molecular biology have revolutionized the concept of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumors (GIST) than the past. Indeed, from being defined as GIST without KIT or PDGFRA mutations, we are now faced with the opposite scenario, where KIT/PDGFRA WT GIST are positively defined according to their specific molecular alterations. In particular, if until recently KIT/PDGFRA GIST without abnormalities of KIT, PDGFRA, SDH, and the RAS signaling pathway were referred as quadruple WT GIST, today also this small subset of GIST is emerging out as a group of heterogeneous distinct entities with multiple different molecular alterations. Therefore, given this still growing and rapidly evolving scenario, the progressive molecular fragmentation may inevitably lead over the time to the disappearance of KIT/PDGFRA WT GIST, destined to be singularly defined by their molecular fingerprint.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Automation & Control Systems

Closed-Loop Frequency Analysis of Reset Control Systems

Ali Ahmadi Dastjerdi, Alessandro Astolfi, Niranjan Saikumar, Nima Karbasizadeh, Duarte Valerio, S. Hassan HosseinNia

Summary: This article presents a closed-loop frequency analysis tool for reset control systems. It provides sufficient conditions for the existence of steady-state response and shows that the steady-state response for periodic inputs is periodic with the same period as the input. The framework presented in this article allows for the computation of steady-state response and defines a notion of closed-loop frequency response, including high order harmonics.

IEEE TRANSACTIONS ON AUTOMATIC CONTROL (2023)

Article Medicine, General & Internal

Genomic Characterization of Rare Primary Cardiac Sarcoma Entities

Livia Gozzellino, Margherita Nannini, Carmine Pizzi, Ornella Leone, Barbara Corti, Valentina Indio, Chiara Baldovini, Pasquale Paolisso, Alberto Foa, Davide Pacini, Gianluca Folesani, Angela Schipani, Alice Costa, Gianandrea Pasquinelli, Maria Abbondanza Pantaleo, Annalisa Astolfi

Summary: Primary cardiac sarcomas are rare malignant tumors with poor prognosis. This study aimed to investigate the gene mutations and expression profiles of two types of cardiac sarcomas, osteosarcoma and leiomyosarcoma, using whole-transcriptome sequencing. The results revealed specific genetic alterations and differential gene expression in these two types of sarcomas compared to other cardiac histotypes, which could be associated with tumorigenesis mechanisms. These findings provide insights for further research on targeted therapies and improving the prognosis of patients with primary cardiac sarcomas.

DIAGNOSTICS (2023)

Article Biochemistry & Molecular Biology

Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK)

Michele Fiore, Alberto Taddia, Valentina Indio, Salvatore Nicola Bertuccio, Daria Messelodi, Salvatore Serravalle, Jessica Bandini, Filippo Spreafico, Daniela Perotti, Paola Collini, Andrea Di Cataldo, Gianandrea Pasquinelli, Francesca Chiarini, Maura Fois, Fraia Melchionda, Andrea Pession, Annalisa Astolfi

Summary: Clear cell sarcoma of the kidney (CCSK) is a rare pediatric renal tumor with worse prognosis than Wilms' tumor. This study aims to investigate the molecular differences between metastatic and localized BCOR-ITD-positive CCSK at diagnosis. The findings suggest that metastatic CCSKs have an overexpression of genes related to the MAPK signaling pathway, and FGF3 may play a role in the acquisition of a more aggressive phenotype.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

The PPAR-γ Agonist Pioglitazone Modulates Proliferation and Migration in HUVEC, HAOSMC and Human Arteriovenous Fistula-Derived Cells

Carmen Ciavarella, Ilenia Motta, Francesco Vasuri, Teresa Palumbo, Anthony Paul Lisi, Alice Costa, Annalisa Astolfi, Sabrina Valente, Piera Versura, Eugenio F. Fornasiero, Raffaella Mauro, Mauro Gargiulo, Gianandrea Pasquinelli

Summary: The failure of arteriovenous fistulas due to intimal hyperplasia is a serious problem for patients undergoing hemodialysis. This study investigated the role of the PPAR-gamma in regulating intimal hyperplasia and found that the PPAR-gamma agonist pioglitazone had a negative effect on cell proliferation and migration.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Oncology

A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes

Sara Mongiorgi, Alessia De Stefano, Stefano Ratti, Valentina Indio, Annalisa Astolfi, Irene Casalin, Andrea Pellagatti, Stefania Paolini, Sarah Parisi, Michele Cavo, Andrea Pession, James A. McCubrey, Pann-Ghill Suh, Lucia Manzoli, Jacqueline Boultwood, Carlo Finelli, Lucio Cocco, Matilde Y. Follo

Summary: This study found that high levels of miR-192-5p are associated with higher overall survival and leukemia-free survival in myelodysplastic syndromes responding to azacitidine and lenalidomide. Moreover, miR-192-5p specifically targets and inhibits BCL2, possibly regulating proliferation and apoptosis and leading to the identification of new therapeutic targets.

CLINICAL EPIGENETICS (2023)

Review Genetics & Heredity

SDHA Germline Mutations in SDH-Deficient GISTs: A Current Update

Angela Schipani, Margherita Nannini, Annalisa Astolfi, Maria A. Pantaleo

Summary: Loss of function of succinate dehydrogenase complex is a characteristic of 20-40% of KIT/PDGFRA-negative GIST. Half of SDH-deficient GIST patients lack SDHx mutations and are caused by hypermethylation of SDHC promoter. The remaining 50% have mutations in SDH subunits, with SDHA mutations being the most common.

GENES (2023)

Article Health Care Sciences & Services

Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma

Martina Ruscelli, Thais Maloberti, Angelo Gianluca Corradini, Francesca Rosini, Giulia Querzoli, Marco Grillini, Annalisa Altimari, Elisa Gruppioni, Viviana Sanza, Alessia Costantino, Riccardo Ciudino, Matteo Errani, Alessia Papapietro, Sara Coluccelli, Daniela Turchetti, Martina Ferioli, Susanna Giunchi, Giulia Dondi, Marco Tesei, Gloria Ravegnini, Francesca Abbati, Daniela Rubino, Claudio Zamagni, Emanuela D'Angelo, Pierandrea De Iaco, Donatella Santini, Claudio Ceccarelli, Anna Myriam Perrone, Giovanni Tallini, Dario de Biase, Antonio De Leo

Summary: This study aims to evaluate the impact of integrated molecular and pathologic risk stratification in the clinical practice of endometrial carcinoma (EC). It found that molecular classes and risk groups were correlated with disease-free survival. The study supports the prognostic importance of EC molecular classification and the essential role of histopathologic assessment in patients' management.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Oncology

A Radiomic-Based Machine Learning Model Predicts Endometrial Cancer Recurrence Using Preoperative CT Radiomic Features: A Pilot Study

Camelia Alexandra Coada, Miriam Santoro, Vladislav Zybin, Marco Di Stanislao, Giulia Paolani, Cecilia Modolon, Stella Di Costanzo, Lucia Genovesi, Marco Tesei, Antonio De Leo, Gloria Ravegnini, Dario De Biase, Alessio Giuseppe Morganti, Luigi Lovato, Pierandrea De Iaco, Lidia Strigari, Anna Myriam Perrone

Summary: This study investigated the potential of radiomic features extracted from pre-surgical CT scans to predict disease-free survival (DFS) in endometrial cancer (EC) patients. Machine learning models achieved high sensitivities and specificities in both training and test sets, showing promise for predicting EC recurrence.

CANCERS (2023)

Review Biochemistry & Molecular Biology

Preclinical Models of Visceral Sarcomas

Alice Costa, Livia Gozzellino, Margherita Nannini, Annalisa Astolfi, Maria Abbondanza Pantaleo, Gianandrea Pasquinelli

Summary: Visceral sarcomas are a rare subtype of soft tissue sarcomas, and understanding their development mechanisms and developing personalized therapies are urgent clinical needs. However, the complex genomic profiles and lack of reliable preclinical models present challenges.

BIOMOLECULES (2023)

Review Biochemistry & Molecular Biology

Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors

Milena Urbini, Sara Bleve, Giuseppe Schepisi, Cecilia Menna, Giorgia Gurioli, Caterina Gianni, Ugo De Giorgi

Summary: Cisplatin-based chemotherapy combinations have greatly improved the outcome of metastatic testicular germ cell tumor patients. However, predicting the prognosis of patients who relapse after first-line therapy remains complex. Molecular selection of patients and validated biomarkers are needed to improve risk stratification and identify novel therapeutic approaches.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Oncology

Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer

M. Nannini, A. Repaci, M. C. Nigro, A. Colapinto, V. Vicennati, T. Maloberti, E. Gruppioni, A. Altimari, E. Solaroli, E. Lodi Rizzini, F. Monari, A. De Leo, S. Damiani, U. Pagotto, M. A. Pantaleo, D. de Biase, G. Talini

Summary: This study retrospectively collected data from a single center in Italy on molecular profiling of patients with advanced differentiated thyroid cancer (DTC) from 2008 to 2022. The results showed a significant correlation between genetic alterations and the development of radioactive iodide refractory (RAI-R) disease. Genetic testing can help identify more aggressive tumors and tumors with actionable gene fusions, guiding clinical decision-making and treatment selection.

ESMO OPEN (2023)

No Data Available